Cellectar Biosciences INC NEW (CLRB) is a publicly traded Healthcare sector company. As of May 21, 2026, CLRB trades at $3.10 with a market cap of $25.09M and a P/E ratio of -0.38. CLRB moved +3.43% today. Year to date, CLRB is -5.37%; over the trailing twelve months it is -59.97%. Its 52-week range spans $2.43 to $67.50. Analyst consensus is strong buy with an average price target of $10.33. Rallies surfaces CLRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded CLRB stock?
Rallies tracks politician and congressional stock disclosures for CLRB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Rallies tracks politician and congressional stock disclosures for CLRB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in CLRB?
Yes. Rallies tracks politician and congressional stock disclosures for CLRB, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CLRB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLRB. It does not provide personalized investment advice.
